New pill for high blood pressure shows promise in early trial
NCT ID NCT00562549
First seen May 03, 2026 · Last updated May 19, 2026 · Updated 3 times
Summary
This study tested a new drug, SLx-2101, in 26 adults with moderate to severe high blood pressure. Participants took the drug once daily for up to 14 days to find the best dose and see how it affects blood pressure. The goal was to check safety and how well the drug lowers blood pressure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Addenbrooke's Hospital
Cambridge, CB2 2QQ, United Kingdom
Conditions
Explore the condition pages connected to this study.